Research Analysts Issue Forecasts for Tilray FY2028 Earnings

Tilray Inc (NASDAQ:TLRY) – Analysts at Atb Cap Markets lowered their FY2028 EPS estimates for shares of Tilray in a research report issued to clients and investors on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of $0.01 per share for the year, down from their prior estimate of $0.06. The consensus estimate for Tilray’s current full-year earnings is ($0.14) per share.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The business had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same period in the previous year, the business posted ($0.10) EPS. The firm’s quarterly revenue was up 13.0% compared to the same quarter last year.

Separately, Roth Mkm decreased their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.

Tilray Stock Up 3.3 %

Shares of NASDAQ:TLRY opened at $1.24 on Wednesday. The company has a market cap of $1.12 billion, a price-to-earnings ratio of -4.50 and a beta of 2.08. Tilray has a one year low of $1.15 and a one year high of $2.97. The firm has a fifty day moving average price of $1.47 and a two-hundred day moving average price of $1.67. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57.

Institutional Trading of Tilray

Hedge funds and other institutional investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Tilray by 22.6% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 39,819 shares of the company’s stock worth $70,000 after purchasing an additional 7,339 shares during the period. Bank of Montreal Can increased its holdings in Tilray by 0.3% in the 3rd quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock worth $3,787,000 after buying an additional 7,406 shares during the period. Arizona State Retirement System boosted its stake in shares of Tilray by 4.4% in the second quarter. Arizona State Retirement System now owns 216,693 shares of the company’s stock worth $360,000 after buying an additional 9,171 shares during the last quarter. Pallas Capital Advisors LLC grew its position in Tilray by 58.1% during the third quarter. Pallas Capital Advisors LLC now owns 31,646 shares of the company’s stock valued at $52,000 after buying an additional 11,632 shares during the period. Finally, Ferguson Wellman Capital Management Inc. purchased a new position in shares of Tilray in the 3rd quarter valued at about $26,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Tilray

In other news, CFO Carl A. Merton purchased 26,000 shares of the stock in a transaction dated Friday, November 15th. The shares were purchased at an average cost of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.87% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.